Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 9/20 | 0.53 |
| ▸ | CCNE1 | P24864 | 3/20 | 0.48 |
| ▸ | CDK2 | P24941 | 3/20 | 0.48 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.47 |
| ▸ | NAMPT | P43490 | 4/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14301590 | 0.93 | GSK3B (0.55) | GSK3BCHEK1NAMPTSMN1; SMN2MEN1 | |
| SCHEMBL14043442 | 0.92 | GSK3B (0.57) | GSK3BCCNE1CDK2CHEK1NAMPT | |
| SCHEMBL14043358 | 0.92 | GSK3B (0.53) | GSK3BCDK2CHEK1NAMPTSMN1; SMN2 | |
| SCHEMBL14418704 | 0.92 | GSK3B (0.53) | GSK3BCCNE1CDK2CHEK1NAMPT | |
| SCHEMBL12953940 | 0.92 | GSK3B (0.53) | GSK3BCHEK1NAMPTSMN1; SMN2MEN1 | |
| SCHEMBL13120610 | 0.91 | GSK3B (0.65) | GSK3BCCNE1CDK2MEN1LMNA | |
| SCHEMBL13288870 | 0.91 | GSK3B (0.56) | GSK3BCCNE1CDK2CHEK1NAMPT | |
| SCHEMBL14301572 | 0.89 | GSK3B (0.52) | GSK3BCDK2CHEK1NAMPTSMN1; SMN2 | |
| SCHEMBL14581372 | 0.88 | GSK3B (0.52) | GSK3BCDK2CHEK1NAMPTSMN1; SMN2 | |
| SCHEMBL14418706 | 0.88 | GSK3B (0.52) | GSK3BCDK2CHEK1NAMPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2194058-A1 | Pyrazolopyrimidines suitable for the treatment of cancer diseases | SCHERING CORPORATION (US) | 2010-06-09 | — | — | EP | disclosed |